The effect of timolol maleate 0.5% gel and timolol maleate 0.5% solution twice daily versus placebo on pulmonary function in older primary open-angle glaucoma or ocular hypertensive patients

被引：0

|

作者：

Lindsay, CL

Stewart, JA

Day, DG

Holmes, KT

Stewart, WC

机构：

[1] Atlanta Res Co, Atlanta, GA USA

[2] Pharmaceut Res Corp, Charleston, SC USA

[3] Univ S Carolina, Sch Med, Columbia, SC 29208 USA

来源：

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2000年 / 41卷 / 04期

关键词：

D O I：

暂无

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

2742B988

引用

收藏

页码：S515 / S515

页数：1

相关论文

共 50 条

[41] Comparison of topical travoprost eye drops given once daily and timolol 0.5% given twice daily in patients with open-angle glaucoma or ocular hypertension
Goldberg, I
Cunha-Vaz, J
Jakobsen, JE
Nordmann, JP
Trost, E
Sullivan, EK
JOURNAL OF GLAUCOMA, 2001, 10 (05) : 414 - 422
[42] ONCE-DAILY VERSUS TWICE-DAILY TIMOLOL MALEATE IN PATIENTS WITH PRIMARY HYPERTENSION
SPENCE, JD
CONLY, BD
JACYK, WR
SMITH, CE
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1982, 32 (06): : 783 - 800
[43] Efficacy and safety of tafluprost 0.0015% and timolol maleate 0.5% fixed combination in patients with ocular hypertension or open-angle glaucoma (vol 15, pg 2255, 2014)
Lorenz, K.
Pfeiffer, N.
EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (16) : 2473 - 2473
[44] Efficacy of Latanoprostene Bunod 0.024% vs. Timolol Maleate 0.5% for Intraocular Pressure Lowering in Patients with Open-Angle Glaucoma or Ocular Hypertension: the LUNAR Study
Peace, James H.
Medeiros, Felipe A.
Martin, Keith R.
Vittitow, Jason L.
Weinreb, Robert N.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
[45] Comparison of topical brinzolamide 1% and dorzolamide 2% eye drops given twice daily in addition to timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension
Michaud, JE
Friren, B
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2001, 132 (02) : 235 - 243
[46] A study of the safety and efficacy of travoprost 0.004%/ timolol 0.5% ophthalmic solution compared to latanoprost 0.005% and timolol 0.5% dosed concomitantly in patients with open-angle glaucoma or ocular hypertension
Rhee, Douglas J.
Peace, James H.
Mallick, Sushanta
Landry, Theresa A.
Bergamini, Michael V. W.
CLINICAL OPHTHALMOLOGY, 2008, 2 (02): : 313 - 319
[47] Short-Term Tolerability of Once-Daily Timolol Hemihydrate 0.5%, Timolol Maleate in Sorbate 0.5%, and Generic Timolol Maleate Gel-Forming Solution 0.5% in Glaucoma and/or Ocular Hypertension: A Prospective, Randomized, Double-Masked, Active-Controlled, Three-Period Crossover Pilot Study
Sonty, Sriram
Mundorf, Thomas K.
Stewart, Jeanette A.
Stewart, William C.
CLINICAL THERAPEUTICS, 2009, 31 (10) : 2063 - 2071
[48] Timolol gel forming solution (0.25% and 0.5%): A new once-daily formulation of timolol maleate for the reduction of elevated intraocular pressure
Shin, D
Garadi, R
Silver, LH
Ratliff, M
von Tress, M
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1999, 40 (04) : S513 - S513
[49] Efficacy and safety of a fixed combination of travoprost 0.004%/timolol 0.5% ophthalmic solution once daily for open-angle glaucoma or ocular hypertension
Schuman, JS
Katz, GJ
Lewis, RA
Henry, JC
Mallick, S
Wells, DT
Sullivan, EK
Landry, TA
Bergamini, MVW
Robertson, SM
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2005, 140 (02) : 242 - 250
[50] Diurnal variation of intraocular pressure in patients with exfoliation glaucoma or primary open-angle glaucoma treated with timolol 0.5%
Konstas, AGP
Mantziris, DA
Cate, EA
Stewart, WC
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1997, 38 (04) : 2592 - 2592

← 1 2 3 4 5 →